The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Koval'chuk V.V.

Gorodskaia bol'nitsa #38 im. N.A. Semashko, Sankt-Peterburg;
Lomonosovskaia tsentral'naia raĭonnaia bol'nitsa, Lomonosov

Zueva I.B.

Saint-Petersburg medical-social Institute, Saint-Petersburg, Russia;
St. Petersburg clinical scientific and practical center for specialized types of medical care, Saint-Petersburg, Russia

Nesterin K.V.

City Clinical Hospital №1, Cheboksary, Russia

Verulashvili I.V.

Department of Neurosciences and Neurology of New Vision University, Tbilisi, Georgia

Kortushvili M.G.

Diagnostic Department of Nervous Diseases, Tbilisi State Medical University, Tbilisi, Georgia

The use of citoflavin in neonatology and pediatrics as a factor improving therapeutic efficacy in patients with central nervous system lesions of various etiology

Authors:

Koval'chuk V.V., Zueva I.B., Nesterin K.V., Verulashvili I.V., Kortushvili M.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5‑2): 46‑50

DOI: 10.17116/jnevro20181185246

Read: 17580 times

Download PDF (RU)
Contact the author
Table of contents

THE USE OF CITOFLAVIN IN NEONATOLOGY AND PEDIATRICS AS A FACTOR IMPROVING THERAPEUTIC EFFICACY IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LESIONS OF VARIOUS ETIOLOGY
THE USE OF CITOFLAVIN IN NEONATOLOGY AND PEDIATRICS AS A FACTOR IMPROVING THERAPEUTIC EFFICACY IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LESIONS OF VARIOUS ETIOLOGY

To cite this article:

Koval'chuk VV, Zueva IB, Nesterin KV, Verulashvili IV, Kortushvili MG. The use of citoflavin in neonatology and pediatrics as a factor improving therapeutic efficacy in patients with central nervous system lesions of various etiology. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5‑2):46‑50. (In Russ.)
https://doi.org/10.17116/jnevro20181185246

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inso­mnia in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):46-51
Surgical treatment of intracerebral meta­stases of Ewing sarcoma in children. Case report and review. Burdenko's Journal of Neurosurgery. 2025;(2):92-96
Adju­vant pharmacological modu­lation with Cyto­flavin in reha­bilitation at stages 2—3 in patients with acute cere­bral insu­fficiency and post-intensive care syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):78-85
Methodology and semiotics of lung ultrasound in ICU children. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):90-100
Effe­ctiveness of lower body perfusion stra­tegy for prevention of renal injury in infa­nts unde­rgoing aortic arch repair. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):142-149
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Rela­tionship between para­meters of impu­lse osci­llometry and spirometry in children. Russian Journal of Preventive Medi­cine. 2025;(4):89-93
Diagnostic and prognostic pote­ntial of modern biomarkers in community-acquired pneumonia in children. Russian Journal of Preventive Medi­cine. 2025;(4):130-135
Modern approaches to diagnosis and treatment of postinfectious asthenic syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):42-52
Pathogenetic aspe­cts of autoantibody formation to central nervous system stru­ctures in patients with ence­phalitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):53-58
Abstract:

Possibilities of increasing the therapeutic efficacy in patients with perinatal central nervous system (CNS) lesions of hypoxic-ischemic and infectious etiology are considered. Some questions of pathophysiological features of hypoxic-ischemic CNS disorders in newborns and their connection with further cascade of pathological changes in organs and systems are highlighted. In this light, the authors substantiate the need for adequate and effective neuro- (cerebro-) protection by the timely antioxidant energy correction and antihypoxic therapy with cytoflavin. The use of cytoflavin is justified in terms of efficacy and safety and can be recommended for use in practical health care in neonatology and pediatrics.

Keywords:

perinatal lesions of the central nervous system
hypoxic-ischemic disorders
cytoflavin
children

Authors:

Koval'chuk V.V.

Gorodskaia bol'nitsa #38 im. N.A. Semashko, Sankt-Peterburg;
Lomonosovskaia tsentral'naia raĭonnaia bol'nitsa, Lomonosov

Zueva I.B.

Saint-Petersburg medical-social Institute, Saint-Petersburg, Russia;
St. Petersburg clinical scientific and practical center for specialized types of medical care, Saint-Petersburg, Russia

Nesterin K.V.

City Clinical Hospital №1, Cheboksary, Russia

Verulashvili I.V.

Department of Neurosciences and Neurology of New Vision University, Tbilisi, Georgia

Kortushvili M.G.

Diagnostic Department of Nervous Diseases, Tbilisi State Medical University, Tbilisi, Georgia

Close metadata

References:

  1. Guide to neonatology. Ed. Yatsyk G.V. M.: Izdatel’stvo Gardarika; 2004. (In Russ.)
  2. Avery B, MacDonald G, Mullett M, Seshia M. Avery’s neonatology: pathophysiology and management of the newborn (6th edition). Lippincott Williams & Wilkins; 2005.
  3. Shabalov NP. Neonatology. M.: MEDpress-inform; 2006. (In Russ.)
  4. Neonatology. National leadership. Pod red. akad. RAMN Volodina N.N. M: GEOTAR-Media; 2007. (In Russ.)
  5. Chekhonin VP, Dmitrieva TB, Zhirkov YuA. Immunochemical analysis of neurospecific antigens. M.: Medicina; 2000. (In Russ.)
  6. Volodin NN, Rogatkin SO, Medvedev MI. Actual problems of perinatal neurology at the present stage. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2001;101:7:4-9. PMID: 11523394. (In Russ.)
  7. Volpe JJ. Neurology of the Newborn. 5th ed. Philadelphia: Elsevier; 2008.
  8. Rogatkin SO, Lyudkovskaya EV, Volodin NN. Treatment of children who underwent perinatal hypoxia in the period of early neonatal adaptation. Vopr ginekologii, akusherstva i perinatologii. 2005;4:3:37-40. (In Russ.)
  9. Raju Tonse NK, Ariagno RL, Higgins R, et al. Research in Neonatology for the 21st Century: Executive Summary of the National Institute of Child Health and Human Development — American Academy of Pediatrics Workshop. Part I: Academic Issues. Pediatrics. 2005;115:468-474.
  10. Perlman JM. Neurology: neonatology questions and controversies. Consulting editor, Richard A. Polin. Saunders-Elsevier; 2008.
  11. Golubkina NP, Chekhonin VP, Rogatkin SO. Immunochemical analysis of neurospecific proteins in assessing the functional state of the central nervous system of newborns from twins. Vopr praktich pediat. 2007;1:5-10. (In Russ.)
  12. Volpe JJ. Encephalopathy of prematurity includes neuronal abnormalitites. Pediatrics. 2005;116:221-225.
  13. Merenstein GB, Gardner SL. Handbook of neonatal intensive care. 6th ed. 2006.
  14. Volodin NN, Rogatkin SO. Modern approaches to complex therapy of perinatal CNS lesions in newborns. Farmateka. 2004;1:72-83. (In Russ.)
  15. Suslina ZA, Tanashyan MM, Smirnova IN, Kashina EM, Fedorova TN, Fedin PA. Antioxidant and neurotrophic action of cytoflavin in chronic cerebrovascular diseases. Vestnik SPbGMA. 2002;3:110-114. (In Russ.)
  16. Skvortsova VI, Efremova NV, Shamalov NA. Cerebral ischemia and neuroprotection. Kachestvo zhizni. Medicina. 2006;2:35-42. (In Russ.)
  17. Koval’chuk VV, Hafizova TL, Galkin AS. The use of neurometabolic treatment in the complex rehabilitation in poststroke patients. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114(11):61-66. PMID: 25591638. (In Russ.)
  18. Fedin AI, Rumjantseva SA, Piradov MA. Efficacy of the neurometabolic titer of cytoflavin in cerebral infarcts. Vestnik SPb GMA. 2005;1:13-19. (In Russ.)
  19. Bul’on VV, Hnychenko LS, Sapronov NS. Correction of the effects of postischemic reperfusion injury of the brain with cytoflavin. Bjull Jeksperim Biologii i mediciny. 2000;129(2):149-151. (In Russ.)
  20. Afanas’ev VV. Cytoflavin in intensive care. SPb.: Taktik-Studio; 2005. (In Russ.)
  21. Bohan NA, Ivanova SA, Terovskij SS, Abushaeva MO, Safiullina VV, Skripka NM, Rakitina NM, Fedorenko OJu, Ljashenko GP. The use of cytoflavin in the treatment of withdrawal syndrome in patients with alcoholism. A Manual for Physicians. SPb.—Tomsk: Taktik-Studio; 2006. (In Russ.)
  22. Guide to children’s endocrinology. Pod red. Bruka Ch.G.D., Braun R.S. M.: GEOTAR-Media; 2009. (In Russ.)
  23. Alimov AV, Nasirova UF. The state of health of children with neonatal transient hypothyroidism. Pediatrija. 2005;1:21-26. (In Russ.)
  24. Strukov VI, Maksimova MN, Kuptsova TA, Lysev SF, Shherbakova JuG. Efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in 1-month old children with transient neonatal hypothyroidism. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(10):17-20. (In Russ.) https://doi.org/10.17116/jnevro201511510117-20
  25. Rogatkin SO, Volodin NN, Degtjareva MG, Grebennikova OV, Marganija MSh, Serova ND. Current approaches to cerebroprotective treatment of premature newborns in reanimation and intensive care departments. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2011;111(1):27-32. PMID: 21350408. (In Russ.)
  26. Antonov AG, Burkova AS, Im VL, Rogatkin SO. Efficacy of cytoflavin in intensive care for premature newborns with cerebral ischemia. Rossijskij vestnik perinatologii i pediatrii. 2010;1:26-32. (In Russ.)
  27. Skripchenko NV, Egorova ES. Cytoflavin in the complex treatment of neuroinfections in children. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2011;111(9):28-31. PMID: 22027666. (In Russ.)
  28. Judenkova O, Zhukov V. The use of cytoflavin in the early hours of acute cerebrovascular ischemia. Vrach. 2006;5:67-70. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.